224 related articles for article (PubMed ID: 9653099)
1. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I.
Sutterwala FS; Noel GJ; Salgame P; Mosser DM
J Exp Med; 1998 Jul; 188(1):217-22. PubMed ID: 9653099
[TBL] [Abstract][Full Text] [Related]
2. Selective suppression of interleukin-12 induction after macrophage receptor ligation.
Sutterwala FS; Noel GJ; Clynes R; Mosser DM
J Exp Med; 1997 Jun; 185(11):1977-85. PubMed ID: 9166427
[TBL] [Abstract][Full Text] [Related]
3. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.
Gerber JS; Mosser DM
J Immunol; 2001 Jun; 166(11):6861-8. PubMed ID: 11359846
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
5. The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.
Gallo P; Gonçalves R; Mosser DM
Immunol Lett; 2010 Oct; 133(2):70-7. PubMed ID: 20670655
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages.
Józefowski S; Kobzik L
J Leukoc Biol; 2004 Nov; 76(5):1066-74. PubMed ID: 15316030
[TBL] [Abstract][Full Text] [Related]
7. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
[TBL] [Abstract][Full Text] [Related]
8. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Polarization Modulates FcγR- and CD13-Mediated Phagocytosis and Reactive Oxygen Species Production, Independently of Receptor Membrane Expression.
Mendoza-Coronel E; Ortega E
Front Immunol; 2017; 8():303. PubMed ID: 28396660
[TBL] [Abstract][Full Text] [Related]
10. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
11. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R.
Mold C; Rodriguez W; Rodic-Polic B; Du Clos TW
J Immunol; 2002 Dec; 169(12):7019-25. PubMed ID: 12471137
[TBL] [Abstract][Full Text] [Related]
13. A novel phenotype for an activated macrophage: the type 2 activated macrophage.
Anderson CF; Mosser DM
J Leukoc Biol; 2002 Jul; 72(1):101-6. PubMed ID: 12101268
[TBL] [Abstract][Full Text] [Related]
14. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
Abdollahi-Roodsaz S; Koenders MI; Walgreen B; Bolscher J; Helsen MM; van den Bersselaar LA; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2013 Oct; 65(10):2583-93. PubMed ID: 23860661
[TBL] [Abstract][Full Text] [Related]
16. Benzo(a)pyrene attenuates the pattern-recognition-receptor induced proinflammatory phenotype of murine macrophages by inducing IL-10 expression in an aryl hydrocarbon receptor-dependent manner.
Fueldner C; Kohlschmidt J; Riemschneider S; Schulze F; Zoldan K; Esser C; Hauschildt S; Lehmann J
Toxicology; 2018 Nov; 409():80-90. PubMed ID: 30053493
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.
van Lent P; Nabbe KC; Boross P; Blom AB; Roth J; Holthuysen A; Sloetjes A; Verbeek S; van den Berg W
Am J Pathol; 2003 Nov; 163(5):1839-48. PubMed ID: 14578184
[TBL] [Abstract][Full Text] [Related]
18. Skewed balance in basal expression and regulation of activating v inhibitory Fcgamma receptors in macrophages of collagen induced arthritis sensitive mice.
Blom AB; van Lent PL; Holthuysen AE; Jacobs C; van den Berg WB
Ann Rheum Dis; 2003 May; 62(5):465-71. PubMed ID: 12695162
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10.
van Lent PL; Blom AB; Grevers L; Sloetjes A; van den Berg WB
Ann Rheum Dis; 2007 Mar; 66(3):334-40. PubMed ID: 17068066
[TBL] [Abstract][Full Text] [Related]
20. Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII.
Boross P; van Lent PL; Martin-Ramirez J; van der Kaa J; Mulder MH; Claassens JW; van den Berg WB; Arandhara VL; Verbeek JS
J Immunol; 2008 Apr; 180(7):5083-91. PubMed ID: 18354234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
